Journal of General Virology, Vol 78, 3195-3206, Copyright © 1997 by Society for General Microbiology

ARTICLES

Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions

G Taylor, LH Thomas, JM Furze, RS Cook, SG Wyld, R Lerch, R Hardy and GW Wertz
Institute for Animal Health, Compton, Newbury, Berkshire, UK. animal.health@bbsrc.ac.uk

The immunogenicity and protective efficacy of recombinant vaccinia viruses (rVV) encoding the F, G, N or M2 (22K) proteins of bovine respiratory syncytial virus (BRSV) were evaluated in calves, the natural host for BRSV. Calves were vaccinated either by scarification or intratracheally with rVV and challenged 6 to 7 weeks later with BRSV. Although replication of rVV expressing the F protein in the respiratory tract was limited after intratracheal vaccination, the levels of serum and pulmonary antibody were similar to those induced following scarification. The serum antibody response induced by the F protein was biased in favour of IgG1 antibody, whereas the G and the N proteins induced similar levels of IgG1:IgG2, and antibody was undetectable in calves primed with the M2 protein. The F protein induced neutralizing antibodies, but only low levels of complement- dependent neutralizing antibodies were induced by the G protein, and antibody induced by the N protein was not neutralizing. The F and N proteins primed calves for BRSV-specific lymphocyte proliferative responses, whereas proliferative responses were detected in calves primed with the G protein only after BRSV challenge. The M2 protein primed lymphocytes in only one out of five calves. Although there were differences in the immune responses induced by the rVVs, the F, G and N, but not the M2, proteins induced significant protection against BRSV infection and, in contrast with the enhanced lung pathology seen in mice vaccinated with rVV expressing individual proteins of human (H)RSV, there was a reduction in lung pathology in calves.

This article has been cited by other articles:

				M. Boxus, M. Tignon, S. Roels, J.-F. Toussaint, K. Walravens, M.-A. Benoit, P. Coppe, J.-J. Letesson, C. Letellier, and P. Kerkhofs DNA Immunization with Plasmids Encoding Fusion and Nucleocapsid Proteins of Bovine Respiratory Syncytial Virus Induces a Strong Cell-Mediated Immunity and Protects Calves against Challenge J. Virol., July 1, 2007; 81(13): 6879 - 6889. [Abstract] [Full Text] [PDF]

				J.-F. Valarcher, J. Furze, S. G. Wyld, R. Cook, G. Zimmer, G. Herrler, and G. Taylor Bovine respiratory syncytial virus lacking the virokinin or with a mutation in furin cleavage site RA(R/K)R109 induces less pulmonary inflammation without impeding the induction of protective immunity in calves J. Gen. Virol., June 1, 2006; 87(6): 1659 - 1667. [Abstract] [Full Text] [PDF]

				S. Biacchesi, Q. N. Pham, M. H. Skiadopoulos, B. R. Murphy, P. L. Collins, and U. J. Buchholz Infection of Nonhuman Primates with Recombinant Human Metapneumovirus Lacking the SH, G, or M2-2 Protein Categorizes Each as a Nonessential Accessory Protein and Identifies Vaccine Candidates J. Virol., October 1, 2005; 79(19): 12608 - 12613. [Abstract] [Full Text] [PDF]

				J.-F. Valarcher, J. Furze, S. Wyld, R. Cook, K.-K. Conzelmann, and G. Taylor Role of Alpha/Beta Interferons in the Attenuation and Immunogenicity of Recombinant Bovine Respiratory Syncytial Viruses Lacking NS Proteins J. Virol., August 1, 2003; 77(15): 8426 - 8439. [Abstract] [Full Text] [PDF]

				U. Schmidt, J. Beyer, U. Polster, L. J. Gershwin, and U. J. Buchholz Mucosal Immunization with Live Recombinant Bovine Respiratory Syncytial Virus (BRSV) and Recombinant BRSV Lacking the Envelope Glycoprotein G Protects against Challenge with Wild-Type BRSV J. Virol., October 25, 2002; 76(23): 12355 - 12359. [Abstract] [Full Text] [PDF]

				U. J. Buchholz, H. Granzow, K. Schuldt, S. S. Whitehead, B. R. Murphy, and P. L. Collins Chimeric Bovine Respiratory Syncytial Virus with Glycoprotein Gene Substitutions from Human Respiratory Syncytial Virus (HRSV): Effects on Host Range and Evaluation as a Live-Attenuated HRSV Vaccine J. Virol., February 1, 2000; 74(3): 1187 - 1199. [Abstract] [Full Text]